Compile Data Set for Download or QSAR
Report error Found 284 for UniProtKB: P26012
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50464108(CHEMBL4241824)
Affinity DataKd:  2.80nMAssay Description:Binding affinity to human integrin alphaVbeta8 after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50464108(CHEMBL4241824)
Affinity DataKd:  2.70nMAssay Description:Binding affinity to human integrin alphaVbeta8 after 2 hrs by liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50530090(CHEMBL4443665)
Affinity DataIC50: 0.0600nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50530090(CHEMBL4443665)
Affinity DataIC50: 0.0600nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-5/beta-6/beta-8(Human)
Scifluor Life Sciences

US Patent
LigandPNGBDBM297773(US10118929, Compound A1)
Affinity DataIC50: 0.130nMAssay Description:The optimized protocol was validated by employing reference compounds such as Cilengitide (+Vβ3/αVβ5−VN interaction) and CWHM12 ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279573((3S)-3-(3,5-dibromophenyl)-3-[[2-[[5-[(5-hydroxy-1...)
Affinity DataIC50: 0.200nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50497716(CHEMBL3319237)
Affinity DataIC50: 0.200nMAssay Description:Antagonist activity at alphavbeta8 integrin receptor (unknown origin) by cell-free ELISAMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279573((3S)-3-(3,5-dibromophenyl)-3-[[2-[[5-[(5-hydroxy-1...)
Affinity DataIC50: 0.200nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279560((3S)-3-(3,5-dibromophenyl)-3-(2-(3-hydroxy-5-((5-h...)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279562((3S)-3-[3-chloro-5-(difluoromethyl)phenyl)-3-(2-(3...)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279568((3S)-3-[3-bromo-5-(trifluoromethyl)phenyl]-3-[[2-[...)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279569((3S)-3-[3,5-bis(trifluoromethyl)phenyl)-3-(2-(3-hy...)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279575((3S)-3-[3-chloro-5-(trifluoromethoxy)phenyl)-3-(2-...)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279576((3S)-3-(3-bromo-5-(trifluoromethoxy)phenyl)-3-(2-(...)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279560((3S)-3-(3,5-dibromophenyl)-3-(2-(3-hydroxy-5-((5-h...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279562((3S)-3-[3-chloro-5-(difluoromethyl)phenyl)-3-(2-(3...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279568((3S)-3-[3-bromo-5-(trifluoromethyl)phenyl]-3-[[2-[...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279569((3S)-3-[3,5-bis(trifluoromethyl)phenyl)-3-(2-(3-hy...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279575((3S)-3-[3-chloro-5-(trifluoromethoxy)phenyl)-3-(2-...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279576((3S)-3-(3-bromo-5-(trifluoromethoxy)phenyl)-3-(2-(...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279563((3S)-3-[3-bromo-5-(difluoromethyl)phenyl)-3-(2-(3-...)
Affinity DataIC50: 0.400nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279566((3S)-3-[3-chloro-5-(trifluoromethyl)phenyl]3-[[2-[...)
Affinity DataIC50: 0.400nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279567((3S)-3-(3-bromo-5-chloro-phenyl)-3-[[2-[[5-[(5-hyd...)
Affinity DataIC50: 0.400nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279563((3S)-3-[3-bromo-5-(difluoromethyl)phenyl)-3-(2-(3-...)
Affinity DataIC50: 0.400nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279566((3S)-3-[3-chloro-5-(trifluoromethyl)phenyl]3-[[2-[...)
Affinity DataIC50: 0.400nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279567((3S)-3-(3-bromo-5-chloro-phenyl)-3-[[2-[[5-[(5-hyd...)
Affinity DataIC50: 0.400nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279561((3S)-3-(3-bromo-5-(trifluoromethyl)phenyl)-3-(2-(3...)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279565((3S)-3-[3-bromo-5-chloro-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279561((3S)-3-(3-bromo-5-(trifluoromethyl)phenyl)-3-(2-(3...)
Affinity DataIC50: 0.5nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279565((3S)-3-[3-bromo-5-chloro-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.5nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279564((3S)-3-[3-chloro-5-(trifluoromethyl)phenyl)-3-(2-(...)
Affinity DataIC50: 0.600nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279570((3S)-3-[3-bromo-5-methyl-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.600nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279564((3S)-3-[3-chloro-5-(trifluoromethyl)phenyl)-3-(2-(...)
Affinity DataIC50: 0.600nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279570((3S)-3-[3-bromo-5-methyl-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.600nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50209461((3S)-3-(3-bromo-5-chloro-2-hydroxyphenyl)-3-(2-(3-...)
Affinity DataIC50: 0.650nMAssay Description:Antagonist activity at human recombinant alphavbeta8 integrin receptor expressed in HEK293 cells after 4 hrs using p-nitrophenyl phosphate by colorim...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279571((3S)-3-[3-chloro-5-methyl-phenyl)-3-(2-(3-hydroxy-...)
Affinity DataIC50: 0.700nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279571((3S)-3-[3-chloro-5-methyl-phenyl)-3-(2-(3-hydroxy-...)
Affinity DataIC50: 0.700nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279572((3S)-3-[3-bromo-5-fluoro-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279572((3S)-3-[3-bromo-5-fluoro-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 1nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279574((3S)-3-[3,5-dichloro-phenyl)-3-(2-(3-hydroxy-5-((5...)
Affinity DataIC50: 1.10nMpH: 7.4 T: 2°CAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM C...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279574((3S)-3-[3,5-dichloro-phenyl)-3-(2-(3-hydroxy-5-((5...)
Affinity DataIC50: 1.10nMAssay Description:Recombinant human LAP protein (R&D Systems, Inc, 246-LP) diluted to 0.5 g/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50497714(Glpg-0187 | Glpg0187)
Affinity DataIC50: 1.20nMAssay Description:Antagonist activity at alphavbeta8 integrin receptor (unknown origin) by cell-free ELISAMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50497714(Glpg-0187 | Glpg0187)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of ligand binding to integrin alphavbeta8 (unknown origin) expressed in baculovirus expression system after 2 hrs by solid-phase assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50530119(CHEMBL4449438)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50530119(CHEMBL4449438)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50530088(CHEMBL4520646)
Affinity DataIC50: 1.5nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50530088(CHEMBL4520646)
Affinity DataIC50: 1.5nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50209457((3S)-3-(3-bromo-5-chloro-2-hydroxyphenyl)-3-(2-(3-...)
Affinity DataIC50: 1.70nMAssay Description:Antagonist activity at human recombinant alphavbeta8 integrin receptor expressed in HEK293 cells after 4 hrs using p-nitrophenyl phosphate by colorim...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50530098(CHEMBL4584228)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-8(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50530098(CHEMBL4584228)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 284 total ) | Next | Last >>
Jump to: